These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34952210)

  • 21. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
    Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study.
    Ramírez Mena A; Thiam M; Ka D; Niang I; Tine J; Fortes L; Ndiaye K; Ndiaye O; Fall M; Gaye A; Ngom NF; Fall F; Berzigotti A; Kirk GD; Jaquet A; Seydi M; Wandeler G;
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):539-549. PubMed ID: 38588691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa.
    Coffie PA; Egger M; Vinikoor MJ; Zannou M; Diero L; Patassi A; Kuniholm MH; Seydi M; Bado G; Ocama P; Andersson MI; Messou E; Minga A; Easterbrook P; Anastos K; Dabis F; Wandeler G;
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):706. PubMed ID: 29143625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBV co-infection is associated with persistently elevated liver stiffness measurement in HIV-positive adults: A 6-year single-centre cohort study in Nigeria.
    Rivera AS; Machenry S; Okpokwu J; Olatunde B; Ugoagwu P; Auwal M; Sule H; Agaba P; Agbaji OO; Thio CL; Murphy RL; Hawkins C
    Antivir Ther; 2021 Nov; 26(6-8):106-116. PubMed ID: 35485338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4
    Kouamé GM; Gabillard D; Moh R; Badje A; Ntakpé JB; Emième A; Maylin S; Toni TD; Ménan H; Zoulim F; Danel C; Anglaret X; Eholié S; Lacombe K; Boyd A
    Antivir Ther; 2021; 26(1-2):25-33. PubMed ID: 35485344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric HIV-HBV Coinfection in Lusaka, Zambia: Prevalence and Short-Term Treatment Outcomes.
    Peebles K; Nchimba L; Chilengi R; Bolton Moore C; Mubiana-Mbewe M; Vinikoor MJ
    J Trop Pediatr; 2015 Dec; 61(6):464-7. PubMed ID: 26338421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
    Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
    Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study.
    Jaquet A; Wandeler G; Nouaman M; Ekouevi DK; Tine J; Patassi A; Coffie PA; Tanon A; Seydi M; Attia A; Dabis F
    J Int AIDS Soc; 2017 Feb; 19(1):21424. PubMed ID: 28362065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occult hepatitis B virus coinfection in HIV-positive African migrants to the UK: a point prevalence study.
    Chadwick D; Doyle T; Ellis S; Price D; Abbas I; Valappil M; Geretti AM
    HIV Med; 2014 Mar; 15(3):189-92. PubMed ID: 24118868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
    Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH
    BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.
    Kim HN; Newcomb CW; Carbonari DM; Roy JA; Torgersen J; Althoff KN; Kitahata MM; Reddy KR; Lim JK; Silverberg MJ; Mayor AM; Horberg MA; Cachay ER; Kirk GD; Sun J; Hull M; Gill MJ; Sterling TR; Kostman JR; Peters MG; Moore RD; Klein MB; Lo Re V;
    Hepatology; 2021 Sep; 74(3):1190-1202. PubMed ID: 33780007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
    Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
    Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Field performance of the Determine HBsAg point-of-care test for diagnosis of hepatitis B virus co-infection among HIV patients in Zambia.
    Chisenga CC; Musukuma K; Chilengi R; Zürcher S; Munamunungu V; Siyunda A; Ojok D; Bauer S; Wandeler G; Vinikoor M;
    J Clin Virol; 2018 Jan; 98():5-7. PubMed ID: 29175231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication.
    Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C;
    Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
    Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
    Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
    Seremba E; Ocama P; Ssekitoleko R; Mayanja-Kizza H; Adams SV; Orem J; Katabira E; Reynolds SJ; Nabatanzi R; Casper C; Phipps W
    Vaccine; 2021 Feb; 39(8):1265-1271. PubMed ID: 33516601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.
    Katwesigye E; Seremba E; Semitala F; Ocama P
    Afr Health Sci; 2017 Dec; 17(4):974-978. PubMed ID: 29937867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B screening practices and viral control among persons living with HIV in urban Senegal.
    Ramírez Mena A; Tine JM; Fortes L; Ndiaye O; Ka D; Ngom NF; Ramette A; Bittel P; Seydi M; Wandeler G;
    J Viral Hepat; 2022 Jan; 29(1):60-68. PubMed ID: 34610183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.